Detalhe da pesquisa
1.
Congenital myasthenic syndromes in adults: clinical features, diagnosis and long-term prognosis.
Brain
; 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38696726
2.
Long-term oncological results of percutaneous radiofrequency ablation for intrahepatic cholangiocarcinoma.
Liver Int
; 44(6): 1363-1372, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38436538
3.
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial.
Lancet Oncol
; 24(12): 1399-1410, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38039993
4.
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.
N Engl J Med
; 382(20): 1894-1905, 2020 05 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32402160
5.
Hypersensitivity infusion-associated reactions induced by enzyme replacement therapy in a cohort of patients with late-onset Pompe disease: An experience from the French Pompe Registry.
Mol Genet Metab
; 139(3): 107611, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37285781
6.
Surgical resection versus transarterial chemoembolization followed by moderately hypofractionated radiotherapy in hepatocellular carcinoma.
Strahlenther Onkol
; 199(3): 293-303, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36441171
7.
Immunotherapy in hepatocellular carcinoma: How does underlying liver disease influence therapeutic strategy and outcomes?
Liver Int
; 43(3): 546-557, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36571256
8.
RNA helicase DDX5 enables STAT1 mRNA translation and interferon signalling in hepatitis B virus replicating hepatocytes.
Gut
; 71(5): 991-1005, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34021034
9.
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 23(8): 995-1008, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35798016
10.
Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial.
Lancet Oncol
; 23(1): 77-90, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34914889
11.
Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma.
J Hepatol
; 76(4): 862-873, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34902530
12.
Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial.
Lancet Oncol
; 22(7): 991-1001, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34051880
13.
Health-related quality-of-life impact of pembrolizumab versus best supportive care in previously systemically treated patients with advanced hepatocellular carcinoma: KEYNOTE-240.
Cancer
; 127(6): 865-874, 2021 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33231873
14.
Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpression.
Br J Cancer
; 125(2): 190-199, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33824476
15.
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma.
N Engl J Med
; 379(1): 54-63, 2018 Jul 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29972759
16.
Deep phenotyping of an international series of patients with late-onset dysferlinopathy.
Eur J Neurol
; 28(6): 2092-2102, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33715265
17.
External validation of the French alpha-fetoprotein model for hepatocellular carcinoma liver transplantation in a recent unicentric cohort - a retrospective study.
Transpl Int
; 34(3): 535-545, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33449394
18.
Impact of 2016 Enhanced Recovery After Surgery (ERAS) Recommendations on Outcomes after Hepatectomy in Cirrhotic and Non-Cirrhotic Patients.
World J Surg
; 45(10): 2964-2974, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34269842
19.
Ramucirumab in elderly patients with hepatocellular carcinoma and elevated alpha-fetoprotein after sorafenib in REACH and REACH-2.
Liver Int
; 40(8): 2008-2020, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32279446
20.
In vitro transformation of primary human hepatocytes: Epigenetic changes and stemness properties.
Exp Cell Res
; 384(2): 111643, 2019 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31557464